Direkt zum Inhalt

HIPRA sponsors the 43rd ASESCU Cuniculture Symposium

Kaninchen

During her presentation, Mrs. Sánchez-Matamoros exposed the main results of a study whose  objective was to evaluate the efficacy of vaccination with ERAVAC® (inactivated vaccine against rabbit haemorrhagic disease type 2) in rabbits for up to 12 months post-vaccination.

These results improve our vaccination knowledge for designing both annual revaccination and emergency vaccination programmes against RHD-2.

With this initiative, HIPRA demonstrates its support for the rabbit industry and affirms its commitment to the prevention of RHD-2.

asescu2

During her presentation, Mrs. Sánchez-Matamoros exposed the main results of a study whose  objective was to evaluate the efficacy of vaccination with ERAVAC® (inactivated vaccine against rabbit haemorrhagic disease type 2) in rabbits for up to 12 months post-vaccination.

These results improve our vaccination knowledge for designing both annual revaccination and emergency vaccination programmes against RHD-2.

With this initiative, HIPRA demonstrates its support for the rabbit industry and affirms its commitment to the prevention of RHD-2.